MedPath

effect of haritaki sunthi guda on ajirna

Phase 1/2
Not yet recruiting
Conditions
Disease of digestive system, unspecified,
Registration Number
CTRI/2019/01/016923
Lead Sponsor
IPGT and RA
Brief Summary

A clinical study was carried out toevaluate effect of *Haritaki+Sunthi+Guda*on symptoms of *Ajirna*. Total sixty patients were registered for clinicalstudy. All those patients were randomly divided into two groups. In Group A **–** subjects weretreated with *Haritaki*+*Sunthi*+*Guda vatika*, while Group B–subjects were treated with placebo (Rosted suji) capsule.

v**Comparison between twogroups In chief complain & associate complain:**

Statisticallysignificant difference was found in *Gourava, Aruchi, Avipaka* and *Vibandh*while statistically insignificant difference was found in complain like *AnilaMudhata* and *Vistambha*. (Table 6.41) Statistically significantdifference was found in *Sadhyobhukta Udgar* while statisticallyinsignificant difference was found in complain like *Shiroshoola, Amlodgar* and*Daha.* (Table 6.44)

 v **Comparison between two groups in *AbhyavaranaShakti* & *Jarana* *Shakti*:**

Whiledoing comparison between two groups in *Abhyavarana Shakti*, Statisticallysignificant difference was found in Quantity of food, Frequency of food,Intensity of hunger and Duration between Two meals*.* (Table 6.47) Andcomparison between two groups in *Jarana Shakti*, Statisticallysignificant difference was found in *Vegotsarga, Laghuta, Utsaha,* *UdgarShuddhi, Klama Parigaman, Kshudha.* (Table 6.50)

v **ALLOVER RESULT OF THE TREATMENT:** (Table 6.51)

After completion of the clinicaltrial in group A, 86.66% of the patients had moderate improvement while 13.33%of the patients had mild improvement. Whereas in group B, 46.66% of thepatients had mild improvements while 53.33% of the patients had un- changed. Inthis study total 60 patients were completed the treatment protocol among them43.33% of the patients had moderate improvement, 30% of the patients had mildimprovement and 26.66% of the patients had Unchanged after treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients will be selected on the basis of classical signs and symptoms of Ajirna i.e. Ajirna symptoms in (cha.chi.15/45-46) like Vishtambha, Sadana, Shiro ruk, Jrumbha, Bhram, Jwara, Chhardi, Arochak, Avipak.

Exclusion Criteria
  • Patients below 20 to above 60 years of age will be excluded.
  • Patients suffering from chronic major illness Like D.M. and contra indication for Haritaki will also excluded like (Ruksha, Krusha, Kshudhita,Trusna.(cha.chi.1/1(35)) Patient suffering from chronic major G.I. track disorder like Ulcerative Colitis, G.E.R.D., Cholera, Dysentery, Celiac Disease and Diverticulitis will also excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical subsidence in the sign and symptoms of Ajirna.15 Days
Improvement in the associated symptoms will be assessed by scoring and gradation pattern.15 Days
Status of Agni will be assessed before and after the treatment.15 Days
Thus obtained data will be assessed statistically and presented along with explanatory notes, discussion and conclusion15 Days
Secondary Outcome Measures
NameTimeMethod
Clinical subsidence in the sign and symptoms of Ajirna.Improvement in the associated symptoms will be assessed by scoring and gradation pattern.

Trial Locations

Locations (1)

IPGT and RA Hospital

🇮🇳

Jamnagar, GUJARAT, India

IPGT and RA Hospital
🇮🇳Jamnagar, GUJARAT, India
Dharmik R Vasani
Principal investigator
7984216763
dharmikvasani46@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.